Zhonghe Genomics successfully completed tens of millions of RMB in pre-Series A financing.

Recently, Tianjin Zhonghe Gene Technology Co., Ltd. completed a Pre-A+ round of financing worth tens of millions of yuan, with China Science and Technology Investment Corporation and Tianjin Port Free Trade Zone Industrial Development Fund jointly investing in this round of financing. Dianshi Capital served as the exclusive financial advisor for this round of financing. The funds raised in this financing will be mainly used to accelerate the development and commercialization of equipment products, and to upgrade the company's synthetic service capabilities.